Enda Shevlin

465 total citations
9 papers, 377 citations indexed

About

Enda Shevlin is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Enda Shevlin has authored 9 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Immunology and 3 papers in Biomedical Engineering. Recurrent topics in Enda Shevlin's work include CAR-T cell therapy research (6 papers), Nanowire Synthesis and Applications (3 papers) and Immune Response and Inflammation (2 papers). Enda Shevlin is often cited by papers focused on CAR-T cell therapy research (6 papers), Nanowire Synthesis and Applications (3 papers) and Immune Response and Inflammation (2 papers). Enda Shevlin collaborates with scholars based in United States, Ireland and South Korea. Enda Shevlin's co-authors include Moonsoo M. Jin, Irene M. Min, Yogindra Vedvyas, Marjan Zaman, Spencer Park, Susan Park, Yen‐Michael S. Hsu, Sinéad M. Miggin, Theresa Scognamiglio and Andrew B. Tassler and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Enda Shevlin

9 papers receiving 372 citations

Peers

Enda Shevlin

ONCOL

IMMUN

BE

MB

GENET

Decheng Song United States

Ronan Thibaut France

Shaun Cordoba United Kingdom

Aleksei Titov Russia

Jiazhen Cui China

Jessica K. Wang United States

Mark Daris United States

Rajat K. Das India

Kyle Wright United States

Xueqiang Zhao China

Decheng Song United States

Enda Shevlin

468 ×1.7

ONCOL

229 ×1.7

IMMUN

173 ×1.5

BE

182 ×2.0

MB

146 ×2.0

GENET

Citations per year, relative to Enda Shevlin Enda Shevlin (= 1×) peers Decheng Song

Countries citing papers authored by Enda Shevlin

Since Specialization

Citations

This map shows the geographic impact of Enda Shevlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enda Shevlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enda Shevlin more than expected).

Fields of papers citing papers by Enda Shevlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enda Shevlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enda Shevlin. The network helps show where Enda Shevlin may publish in the future.

Co-authorship network of co-authors of Enda Shevlin

This figure shows the co-authorship network connecting the top 25 collaborators of Enda Shevlin. A scholar is included among the top collaborators of Enda Shevlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enda Shevlin. Enda Shevlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Gray, Katherine D., Yogindra Vedvyas, Yanping Yang, et al.. (2020). PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid Cancer. Clinical Cancer Research. 26(22). 6003–6016. 35 indexed citations

2.

Gray, Katherine D., Yogindra Vedvyas, Enda Shevlin, et al.. (2018). Abstract 2738: PD-L1/PD-1 checkpoint inhibition in anaplastic thyroid cancer and enhancement of ICAM1-targeted chimeric antigen receptor (CAR)-T cell tumor lysis. Cancer Research. 78(13_Supplement). 2738–2738. 2 indexed citations

3.

Min, Irene M., Enda Shevlin, Yogindra Vedvyas, et al.. (2017). CAR T Therapy Targeting ICAM-1 Eliminates Advanced Human Thyroid Tumors. Clinical Cancer Research. 23(24). 7569–7583. 78 indexed citations

4.

Shevlin, Enda, Spencer Park, Yogindra Vedvyas, et al.. (2017). Abstract 3750: Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity. Cancer Research. 77(13_Supplement). 3750–3750. 1 indexed citations

5.

Park, Spencer, Enda Shevlin, Yogindra Vedvyas, et al.. (2017). Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity. Scientific Reports. 7(1). 14366–14366. 139 indexed citations

6.

Vedvyas, Yogindra, Enda Shevlin, Marjan Zaman, et al.. (2016). Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors. JCI Insight. 1(19). e90064–e90064. 69 indexed citations

7.

Shevlin, Enda & Sinéad M. Miggin. (2014). The TIR-Domain Containing Adaptor TRAM Is Required for TLR7 Mediated RANTES Production. PLoS ONE. 9(9). e107141–e107141. 14 indexed citations

8.

Shevlin, Enda & Rhoda Ashley Morrow. (2014). Comparative performance of the Uni-Gold™ HSV-2 Rapid: A point-of-care HSV-2 diagnostic test in unselected sera from a reference laboratory. Journal of Clinical Virology. 61(3). 378–381. 8 indexed citations

9.

Ahmed, Suaad, et al.. (2013). TRIF-Mediated TLR3 and TLR4 Signaling Is Negatively Regulated by ADAM15. The Journal of Immunology. 190(5). 2217–2228. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact